Exec Summary:The size of the healthtech secondary share sale market is growing rapidly. In 2021, the market was valued at $10.9 billion, and it is expected to reach $26.4 billion by 2028.This growth is being driven by a number of factors, including the increasing number of healthtech companies going public, the growing demand for secondary […]
